论文部分内容阅读
生物医学已进入后基因组时代。随着基因组学技术的日趋完善 ,基因标志物及相应的检测方法已逐步成为肿瘤早期诊断和风险评价的可靠依据 ,并在肿瘤的筛检工作中发挥重要的作用。
Biomedical has entered the post-genomic era. With the improvement of genomics technology, genetic markers and the corresponding detection methods have gradually become the reliable basis for the early diagnosis and risk assessment of tumors, and play an important role in the screening of tumors.